EUVIMEDEUVIMED entdecken
Crossref

Neurocodex as the basis of a national ethical platform for the development and application of neurotechnologies and brain–computer interfaces

M. Fedorov, D Repin, D Bortnikov, D Voshev, O Klivcova, O Klevcova, K Buslov, M Izotova, N Starodubceva, M Lebedev, A Schegoleva, E Nikitin

Pharmacy and Intelligent healthcare · 04.08.2026

DOI: 10.68786/fiiz4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacy and Intelligent healthcare, erschienen am 04.08.2026. Verfasst von M. Fedorov und 11 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The rapid development of neurotechnologies and brain–computer interfaces expand opportunities for diagnosis, treatment, rehabilitation, and restoration of communication while creating new ethical, legal, and organisational risks related to cognitive liberty, personal autonomy, mental privacy, neural data security, and interventions affecting nervous system functions. International documents establish general principles for the responsible development of neurotechnologies; however, mechanisms for their practical implementation, including risk classification, ethics review, audit, monitoring, and allocation of responsibility, remain heterogeneous.

Aim

To conduct a comparative analysis of international ethical and regulatory approaches to the development and application of neurotechnologies and to substantiate the conceptual architecture of the project «Code of Ethics for the Development and Application of Neurotechnologies and Interfaces» (Neurocodex) version 1.0 as the basis of the national lifecycle management system for neurotechnologies and brain–computer interfaces. A normative and conceptual analysis of the Neurocodex and its comparison with international documents, as well as scientific publications on neuroethics, neuro-law, protection of neurodata and regulation of brain–computer interfaces has been carried out. The analysis demonstrated that the Neurocode integrates the principles of human rights and dignity, cognitive liberty, personal autonomy, mental privacy, transparency, fairness, and non-discrimination with mechanisms of risk-based classification, independent ethics review, clinical and cybersecurity requirements, accountability, monitoring, and long-term stewardship. The proposed four-tier risk classification takes into account technology invasiveness, the nature of effects on the nervous system, reversibility of consequences, sensitivity of neural data, algorithmic autonomy, and context of use.

Conclusion

Neurocode version 1.0 may be regarded as a conceptual foundation for a national ethical system for the responsible development and use of neurotechnologies, enabling a transition from general principles to procedures for risk assessment, independent review, audit, monitoring, and long-term stewardship. Its further development requires interdisciplinary testing, formalisation of risk-level criteria, measurable compliance indicators, and harmonisation with current legislation

Zitieren

APA

Fedorov, M., Repin, D., Bortnikov, D., Voshev, D., Klivcova, O., Klevcova, O., Buslov, K., Izotova, M., Starodubceva, N., Lebedev, M., Schegoleva, A., & Nikitin, E. (2026). Neurocodex as the basis of a national ethical platform for the development and application of neurotechnologies and brain–computer interfaces. Pharmacy and Intelligent healthcare. https://doi.org/10.68786/fiiz4

Vancouver

Fedorov M, Repin D, Bortnikov D, Voshev D, Klivcova O, Klevcova O, et al. Neurocodex as the basis of a national ethical platform for the development and application of neurotechnologies and brain–computer interfaces. Pharmacy and Intelligent healthcare. 2026. doi:10.68786/fiiz4

BibTeX
@article{Fedorov2026,
  author = {Fedorov, M. and Repin, D and Bortnikov, D and Voshev, D and Klivcova, O and Klevcova, O and Buslov, K and Izotova, M and Starodubceva, N and Lebedev, M and Schegoleva, A and Nikitin, E},
  title = {Neurocodex as the basis of a national ethical platform for the development and application of neurotechnologies and brain–computer interfaces},
  journal = {Pharmacy and Intelligent healthcare},
  year = {2026},
  doi = {10.68786/fiiz4}
}
Kostenlos starten →